Stay updated on Crenolanib with Salvage Chemo in R/R AML Clinical Trial

Sign up to get notified when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed information about a pilot study involving crenolanib for treating Relapsed/Refractory Acute Myeloid Leukemia (AML) and the addition of new drug names such as Etoposide, Fludarabine, and Idarubicin. The revision number has also been updated from v2.14.4 to v2.15.0.
    Difference
    40%
    Check dated 2025-04-16T20:29:09.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.5%
    Check dated 2025-04-09T14:07:06.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-25T14:51:08.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-03-11T06:15:09.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T22:45:16.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2025-02-17T18:57:30.000Z thumbnail image

Stay in the know with updates to Crenolanib with Salvage Chemo in R/R AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Crenolanib with Salvage Chemo in R/R AML Clinical Trial page.